![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4.35 | 4.20 | 4.50 | 4.35 | 4.35 | 4.35 | 0.00 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.36 | 23.2M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/5/2023 14:43 | I know for a fact that isn't true. As far as I am concerned, there is me and then everyone else, including you Neuts, which may just be one person..... | ![]() timbo_slice | |
15/5/2023 14:29 | Brucie Bonus, you do realise that your sundry conversations with people here are all (ravenna23 and myself excepted) with one and the same ramping liar? | ![]() neutralpov | |
15/5/2023 13:21 | supersonico15 May '23 - 09:44 - 14081 of 14082 0 1 0 -------------------- Wise I am not, but these days I do try to be cautious. ;) | ![]() brucie5 | |
15/5/2023 13:16 | Brucie5 15 May '23 - 08:54 - 14078 > I believe that 2022 results showed revenue at £1.8m with pre-tax loss of £2.6m and cash down to £2m. > Seems obvious that they will need a cash raise, surely? Totally obvious, except to idiots as are to be found here, yes! And a substantial and imminent one too. No reputable lender will touch it, so it will be mega-dilution time.... and then a prepack. Or, perhaps the greedy troughers in the BoD will refund the years or decade of cream they've skimmed off? Oops, saw a flying piggy. | ![]() neutralpov | |
15/5/2023 09:44 | I imagine your not alone with that wise and cautious approach. Good luck to you also. | ![]() supersonico | |
15/5/2023 09:22 | Ok. Well, good luck with that. I wouldn't be investing here again personally until I saw that happen. Smaller AIMers never, of course, let on that they need money until it happens. I have seen the story for years and if they pull it off, of course, the world in theory, would be their oyster! | ![]() brucie5 | |
15/5/2023 09:15 | Quite possibly Brucie and you know my guess but also noted in the recent company report was the statement below .. so an upfront payment from that mystery company may bridge the gap. My guess is Elanco which may have been related to the 'dog' comment from Smith in the recent Investor day video. 'COMPANY OVERVIEW' 'Eden is poised to exploit it's core technologies beyond pesticides and crop protection.'. | ![]() supersonico | |
15/5/2023 08:54 | Continued good news on regs but I believe that 2022 results showed revenue at £1.8m with pre-tax loss of £2.6m and cash down to £2m. Seems obvious that they will need a cash raise, surely? | ![]() brucie5 | |
15/5/2023 07:11 | Eden obtains authorisation for Mevalone in New Zealand | ![]() supersonico | |
14/5/2023 17:26 | From post 14058 Given that this is not my first rodeo I'm guessing (as always) that this is a market subduing tactic in preparation for a Corteva or other whale strategic investment. I don't expect Smith and Co to change their spots so when they make uncharacteristic commentary my attention is guaranteed. AWGATWT. | ![]() supersonico | |
13/5/2023 20:01 | Prime Idiots haven't noticed the directors are NOT buying! ;D and ROTFL! And lol, classic "SUCKER STOCK" (S.S.) per Stockopedia analysis. Why does that "S.S." acronym sound familiar here? | ![]() neutralpov | |
13/5/2023 19:47 | Investing, Should have gone down well. A further example of Eden raising their profile in advance of the wholesome Corteva RNS dropping in the coming. | ![]() supersonico | |
13/5/2023 18:50 | Here's What We Think About Eden Research's CEO Pay And that damning report on massive over-compensation for zero, no, NEGATIVE delivery is dated nearly 3 years ago. Since back then there's been further accumulation of losses and far more snouted from the trough by the greedy blighter. So there's one person/family REALLY happy with the status quo and gravy train. Pig in clover. | ![]() neutralpov | |
13/5/2023 18:41 | hxxps://www.eventbri I wonder how it went? | ![]() investingisatrickygame | |
13/5/2023 07:09 | Yes, Trials for seed treatment (coatings) which is due for commercialization for 2024 growing season and then I think he's referring to SustainE 'within' Pioneer seeds. Interesting Sam Eathington commentary @1hr29m in the Corteva Innovation Web cast in referring to EU approvals sounds very confident in Corteva's 'regulatory capacity to get things approved around the world is quite beneficial there'. Also Eden have Mike Carroll on hand as our trusty Corteva link man to provide network benefits. Also Smith's reference @6.17 to the 80 plus field trials for the insecticide treatment which could again be Corteva @Pioneer or Whale2. If it is Corteva then I'm even more inclined to think we'll see some sort of strategic partnership announcement. The Corteva French commentary regarding the 10x of addressable market that Smith refers to in the investor presentation event is making Corteva a very important partner and they may just want a bit of the ££benefit from the scale they bring to the party in what Sam Eathington calls 'unique value sharing collaborations'. “Our R&D program is also delivering innovation by moving faster on new opportunities such as biologicals to help farmers meet changing food production demands and the potential for double cropping systems that provide another cash crop option for farmers,” said Sam Eathington, Chief Technology and Digital Officer, Corteva Agriscience. “We are using the combination of acquisitions, unique value sharing collaborations, external innovation, and internal R&D capabilities to provide better solutions to farmers as they address new challenges to their operations now and in the future.” Of course with Whale2 onboard as well Eden may have enough leverage to be considered 'external innovation' to them both. What anyone who is paying attention is certainly seeing is a step change in Eden's growth prospects and the PR noise that goes along with that. | ![]() supersonico | |
12/5/2023 22:37 | Are you referring to the evaluation of Eden's product in Corteva seed treatment products across Europe? | ![]() investingisatrickygame | |
12/5/2023 20:53 | Investing, What do you make of Smith's commentary @ 6.55m ? | ![]() supersonico | |
12/5/2023 20:24 | @super On one slide re biopesticides market, value $11 billion globally, sean said that 80-85% of global R and D was being spent in this area. Sean also said that although research is in our name, we are a development company. Quite right! We are now developing multiple products from the same 3 natural active ingredients. That was an excellent presentation for investors to absorb. | ![]() investingisatrickygame | |
12/5/2023 16:43 | Neuts, if your research on EDEN is as good as your research on me, then I'll end up making millions from EDEN. Mango | ![]() timbo_slice | |
12/5/2023 13:31 | Master Investor Show 2023 - Sean Smith - Eden Research plc While Atul watches patiently. | ![]() supersonico | |
12/5/2023 11:08 | Least successful pump I've ever seen..... I do not think the RNS should have any speculative figures - that info should be in the marketing material. | ![]() timbo_slice |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions